vs
Side-by-side financial comparison of Azenta, Inc. (AZTA) and CSW INDUSTRIALS, INC. (CSW). Click either name above to swap in a different company.
CSW INDUSTRIALS, INC. is the larger business by last-quarter revenue ($233.0M vs $148.6M, roughly 1.6× Azenta, Inc.). CSW INDUSTRIALS, INC. runs the higher net margin — 4.4% vs -10.4%, a 14.8% gap on every dollar of revenue. On growth, CSW INDUSTRIALS, INC. posted the faster year-over-year revenue change (20.3% vs 0.8%). CSW INDUSTRIALS, INC. produced more free cash flow last quarter ($22.7M vs $14.7M). Over the past eight quarters, CSW INDUSTRIALS, INC.'s revenue compounded faster (5.1% CAGR vs 4.4%).
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics.
AZTA vs CSW — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $148.6M | $233.0M |
| Net Profit | $-15.4M | $10.3M |
| Gross Margin | 42.9% | 39.7% |
| Operating Margin | -4.9% | 7.4% |
| Net Margin | -10.4% | 4.4% |
| Revenue YoY | 0.8% | 20.3% |
| Net Profit YoY | -15.7% | -61.9% |
| EPS (diluted) | $-0.34 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.6M | $233.0M | ||
| Q3 25 | $159.2M | $277.0M | ||
| Q2 25 | $143.9M | $263.6M | ||
| Q1 25 | $143.3M | $230.5M | ||
| Q4 24 | $147.4M | $193.6M | ||
| Q3 24 | $150.6M | $227.9M | ||
| Q2 24 | $144.3M | $226.2M | ||
| Q1 24 | $136.4M | $210.9M |
| Q4 25 | $-15.4M | $10.3M | ||
| Q3 25 | $50.9M | $40.7M | ||
| Q2 25 | $-48.0M | $40.9M | ||
| Q1 25 | $-47.7M | $35.1M | ||
| Q4 24 | $-11.0M | $26.9M | ||
| Q3 24 | $-6.6M | $36.1M | ||
| Q2 24 | $-6.6M | $38.6M | ||
| Q1 24 | $-137.4M | $31.8M |
| Q4 25 | 42.9% | 39.7% | ||
| Q3 25 | 45.4% | 43.0% | ||
| Q2 25 | 46.2% | 43.8% | ||
| Q1 25 | 43.8% | 44.2% | ||
| Q4 24 | 46.7% | 41.4% | ||
| Q3 24 | 45.5% | 45.6% | ||
| Q2 24 | 44.8% | 47.5% | ||
| Q1 24 | 43.8% | 44.4% |
| Q4 25 | -4.9% | 7.4% | ||
| Q3 25 | 1.2% | 20.5% | ||
| Q2 25 | -1.3% | 20.8% | ||
| Q1 25 | -12.7% | 19.5% | ||
| Q4 24 | -5.9% | 15.3% | ||
| Q3 24 | -3.1% | 22.6% | ||
| Q2 24 | -4.9% | 24.3% | ||
| Q1 24 | -18.1% | 21.0% |
| Q4 25 | -10.4% | 4.4% | ||
| Q3 25 | 32.0% | 14.7% | ||
| Q2 25 | -33.4% | 15.5% | ||
| Q1 25 | -33.3% | 15.2% | ||
| Q4 24 | -7.5% | 13.9% | ||
| Q3 24 | -4.4% | 15.8% | ||
| Q2 24 | -4.5% | 17.1% | ||
| Q1 24 | -100.8% | 15.1% |
| Q4 25 | $-0.34 | $0.62 | ||
| Q3 25 | $1.12 | $2.41 | ||
| Q2 25 | $-1.05 | $2.43 | ||
| Q1 25 | $-1.04 | $2.05 | ||
| Q4 24 | $-0.25 | $1.60 | ||
| Q3 24 | $-0.25 | $2.26 | ||
| Q2 24 | $-0.12 | $2.47 | ||
| Q1 24 | $-2.48 | $2.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $336.6M | $40.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.7B | $1.1B |
| Total Assets | $2.1B | $2.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $336.6M | $40.2M | ||
| Q3 25 | $279.8M | $31.5M | ||
| Q2 25 | $270.0M | $38.0M | ||
| Q1 25 | $253.6M | $225.8M | ||
| Q4 24 | $377.5M | $213.8M | ||
| Q3 24 | $280.0M | $273.2M | ||
| Q2 24 | $336.5M | $18.9M | ||
| Q1 24 | $353.5M | $22.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $800.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $166.0M |
| Q4 25 | $1.7B | $1.1B | ||
| Q3 25 | $1.7B | $1.1B | ||
| Q2 25 | $1.7B | $1.1B | ||
| Q1 25 | $1.7B | $1.1B | ||
| Q4 24 | $1.7B | $1.0B | ||
| Q3 24 | $1.8B | $1.0B | ||
| Q2 24 | $2.0B | $650.2M | ||
| Q1 24 | $2.2B | $615.7M |
| Q4 25 | $2.1B | $2.3B | ||
| Q3 25 | $2.1B | $1.5B | ||
| Q2 25 | $2.0B | $1.5B | ||
| Q1 25 | $2.0B | $1.4B | ||
| Q4 24 | $2.0B | $1.4B | ||
| Q3 24 | $2.1B | $1.4B | ||
| Q2 24 | $2.3B | $1.1B | ||
| Q1 24 | $2.6B | $1.0B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.8M | $28.9M |
| Free Cash FlowOCF − Capex | $14.7M | $22.7M |
| FCF MarginFCF / Revenue | 9.9% | 9.8% |
| Capex IntensityCapex / Revenue | 4.2% | 2.6% |
| Cash ConversionOCF / Net Profit | — | 2.81× |
| TTM Free Cash FlowTrailing 4 quarters | $30.9M | $162.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.8M | $28.9M | ||
| Q3 25 | $2.2M | $61.8M | ||
| Q2 25 | $25.8M | $60.6M | ||
| Q1 25 | $14.4M | $27.3M | ||
| Q4 24 | $29.8M | $11.6M | ||
| Q3 24 | $17.7M | $66.8M | ||
| Q2 24 | $9.8M | $62.7M | ||
| Q1 24 | $8.7M | $22.4M |
| Q4 25 | $14.7M | $22.7M | ||
| Q3 25 | $-5.7M | $58.7M | ||
| Q2 25 | $15.0M | $57.7M | ||
| Q1 25 | $7.0M | $22.8M | ||
| Q4 24 | $22.0M | $8.5M | ||
| Q3 24 | $8.3M | $61.3M | ||
| Q2 24 | $1.3M | $59.6M | ||
| Q1 24 | $428.0K | $17.5M |
| Q4 25 | 9.9% | 9.8% | ||
| Q3 25 | -3.6% | 21.2% | ||
| Q2 25 | 10.4% | 21.9% | ||
| Q1 25 | 4.9% | 9.9% | ||
| Q4 24 | 15.0% | 4.4% | ||
| Q3 24 | 5.5% | 26.9% | ||
| Q2 24 | 0.9% | 26.3% | ||
| Q1 24 | 0.3% | 8.3% |
| Q4 25 | 4.2% | 2.6% | ||
| Q3 25 | 4.9% | 1.1% | ||
| Q2 25 | 7.5% | 1.1% | ||
| Q1 25 | 5.2% | 2.0% | ||
| Q4 24 | 5.3% | 1.6% | ||
| Q3 24 | 6.2% | 2.4% | ||
| Q2 24 | 5.9% | 1.4% | ||
| Q1 24 | 6.1% | 2.3% |
| Q4 25 | — | 2.81× | ||
| Q3 25 | 0.04× | 1.52× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 1.85× | ||
| Q2 24 | — | 1.62× | ||
| Q1 24 | — | 0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZTA
| Multiomics | $67.2M | 45% |
| Core Products | $47.6M | 32% |
| Sample Repository Solutions | $33.8M | 23% |
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
